How Title X Agencies Can Expand Opill Access Office Hours

This event has reached capacity and registration is now closed.

Join the RHNTC for an office hour session on the role Title X agencies play in expanding access both to Opill, the new over-the-counter progesterone-only birth control pill, and to medically accurate information about Opill. This session is open to all Title X staff but may be particularly relevant for those who provide contraceptive counseling.

The hour will begin with a short presentation but most of the session will be dedicated to answering participant questions. Please prepare by looking at the pre-reads/pre-watches below and bringing your Opill questions. 

This office hour is intended for Title X grantee or subrecipient staff. Participants will be approved after registering through Zoom. The session will be limited to 100 registrants.


  • Shannon Bakshian, MBA, MSN, APRN, WHCNP, Associate Medical Director, Planned Parenthood North Central State
  • Meg Sheahan, MSN, CNM, MPH, Senior Clinical Consultant, RHNTC
  • Angie Fellers LeMire, MS, BSN, TTA Provider and Grantee Liaison, RHNTC

Pre-read/pre-watch recommendations:

Learning Objectives:
By the end of this session, participants will be able to:

  • Identify two benefits to Opill becoming available over the counter
  • Identify two potential challenges to accessing Opill
  • Describe two strategies for ensuring clients receive medically accurate Opill information
  • Describe two Opill considerations when providing person-centered contraceptive counseling